title: Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water.
abstract: Dietary calcium supplementation inhibits hyperproliferation of rectal epithelium, possibly by precipitating luminal surfactants and thus preventing their cell-damaging effects. Therefore, we studied the effects of supplemental dietary calcium (35.5 mmol/day) on composition and cytolytic activity of fecal water and on the release of the epithelial marker alkaline phosphatase in 12 healthy volunteers. Fecal water was isolated by low-speed centrifugation. Cytolytic activity was determined as lysis of human erythrocytes by fecal water. Intestinal alkaline phosphatase activity in fecal water was measured with the use of the uncompetitive inhibitor L-phenylalanine. Supplemental calcium increased soluble calcium and decreased soluble P(i). The logarithm of the concentration product of calcium and phosphate was linearly dependent on pH. These observations indicate formation of insoluble calcium phosphate. Supplemental calcium did not alter the total bile acid concentration in fecal water but significantly decreased the ratio of more hydrophobic to more hydrophilic bile acids from 3.3 to 2.3. Calcium also significantly decreased the concentration of fatty acids (from 2.9 to 2.1 mM). Consistent with these decreases in hydrophobic surfactants, calcium decreased the cytolytic activity of fecal water from 47 +/- 9 to 27 +/- 8% (n = 12, P < 0.05). Analogous to the decrease in cytolytic activity, the release of the epithelial marker alkaline phosphatase was also lowered by supplemental calcium. We conclude that supplemental dietary calcium decreases luminal cytotoxic surfactant concentrations and thus inhibits luminal cytolytic activity and the release of the epithelial marker alkaline phosphatase as an indicator of intestinal epitheliolysis. This mechanism may explain how dietary calcium could decrease epithelial cell proliferation.
authors.affiliation: Department of Nutrition, Netherlands Institute for Dairy Research (NIZO), Ede.
authors.forename: J A
authors.initials: JA
authors.lastname: Lapré
authors.forename: H T
authors.initials: HT
authors.lastname: De Vries
authors.forename: D S
authors.initials: DS
authors.lastname: Termont
authors.forename: J H
authors.initials: JH
authors.lastname: Kleibeuker
authors.forename: E G
authors.initials: EG
authors.lastname: De Vries
authors.forename: R
authors.initials: R
authors.lastname: Van der Meer
mesh_terms: D000328:Adult; D000469:Alkaline Phosphatase / Q000378:metabolism; D001647:Bile Acids and Salts / Q000378:metabolism; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism; D005243:Feces / Q000737:chemistry*; D006461:Hemolysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007413:Intestinal Mucosa / Q000378:metabolism*; D008274:Magnesium / Q000378:metabolism; D008297:Male; D010710:Phosphates / Q000378:metabolism; D013261:Sterols / Q000378:metabolism; D014867:Water / Q000378:metabolism
chemical_list: D001647:Bile Acids and Salts; D005227:Fatty Acids; D010710:Phosphates; D013261:Sterols; D014867:Water; D000469:Alkaline Phosphatase; D008274:Magnesium; D002118:Calcium